Related Experiment Video
Updated: Jun 16, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
[Analysis of a severe septic transfusion reaction with standard platelet concentrate]
R Courbil1, J-P Romaszko, H Odent-Malaure
1EFS Auvergne-Loire, boulevard Pasteur, Saint-Etienne, France. remi.courbil@efs.sante.fr
Abstract:
We recently observed a near fatal case of transfusion-transmitted infection with standard platelet concentrate. Streptococcus dysgalactiae subspecies equisimilis was isolated both from donor, residual component container and cultures of the patient's blood. This should question the usefulness of systematic bacterial detection in platelet concentrates, however a lethal accident has occurred recently which escaped bacterial detection. This observation calls for implementation of pathogen inactivation procedures for platelets concentrates.
Insights
A severe transfusion infection from platelet concentrate highlights risks. Current bacterial detection methods may be insufficient, necessitating pathogen inactivation for safer blood products.
Area of Science:
- Transfusion Medicine
- Microbiology
- Infectious Diseases
Background:
- Platelet concentrates are vital for treating thrombocytopenia.
- Bacterial contamination of blood products poses a significant risk to patients.
- Current screening methods aim to minimize but not eliminate microbial transmission.
Observation:
- A near-fatal case of transfusion-transmitted infection occurred.
- Streptococcus dysgalactiae subspecies equisimilis was identified in the donor, residual component, and patient's blood.
- This specific bacterial strain caused a severe transfusion reaction.
Findings:
- Systematic bacterial detection in platelet concentrates may not be fully effective.
- A recent lethal transfusion accident escaped bacterial detection, indicating limitations in current screening.
- The case underscores the potential for serious pathogens to evade standard detection protocols.
Implications:
- Pathogen inactivation technologies for platelet concentrates should be implemented.
- Enhanced safety measures are crucial to prevent transfusion-transmitted bacterial infections.
- Further research into robust screening and inactivation methods is warranted to improve blood product safety.

